180 Degree Capital (NASDAQ:TURN – Get Free Report)‘s stock had its “sell (d-)” rating restated by stock analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.
180 Degree Capital Price Performance
Shares of NASDAQ TURN opened at $3.95 on Wednesday. 180 Degree Capital has a 1 year low of $3.12 and a 1 year high of $4.25. The firm has a 50-day simple moving average of $3.91 and a two-hundred day simple moving average of $3.85.
Institutional Investors Weigh In On 180 Degree Capital
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. One Day In July LLC bought a new position in 180 Degree Capital in the 4th quarter worth about $39,000. StoneX Group Inc. bought a new position in 180 Degree Capital in the fourth quarter worth approximately $44,000. XTX Topco Ltd purchased a new position in 180 Degree Capital during the 1st quarter worth $53,000. Tabor Asset Management LP purchased a new position in 180 Degree Capital during the 1st quarter worth $66,000. Finally, Principal Street Partners LLC raised its position in 180 Degree Capital by 77.5% during the 4th quarter. Principal Street Partners LLC now owns 24,050 shares of the company’s stock valued at $88,000 after purchasing an additional 10,500 shares in the last quarter. Institutional investors own 19.78% of the company’s stock.
180 Degree Capital Company Profile
180 Degree Capital Corp. is a publicly owned corporate pension plan sponsor. It primarily provides its services to pension and profit sharing plans. The firm is a large advisory firm which provides portfolio management for pooled investment vehicles, pension consulting services. It manages separate client focused equity and balanced funds.
Featured Articles
- Five stocks we like better than 180 Degree Capital
- Airline Stocks – Top Airline Stocks to Buy Now
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- Stock Average Calculator
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for 180 Degree Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 180 Degree Capital and related companies with MarketBeat.com's FREE daily email newsletter.